BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Radanstobart readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Radanstobart\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05789069-2514@assetmemo.bio
DTSTAMP:20261121T005707Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Radanstobart: Phase 1 readout est. (NCT05789069)
DESCRIPTION:Radanstobart\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A 
 Study of HFB200603 as a Single Agent and in Combination With Tislelizumab 
 in Adult Patients With Advanced Solid Tumors\nEstimated primary completion
 : December 2026. This is a ClinicalTrials.gov estimate\, not a confirmed r
 eadout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/rada
 nstobart#upcoming-events\nRegistry record: https://clinicaltrials.gov/stud
 y/NCT05789069
URL:https://assetmemo.bio/drug/radanstobart#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
